Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Soma

Showing results (21-30 of 82) with videos related to

Pageof 9
Sort By:
Cancer Biotherapy|January 1, 1994
Antitumor effect of exogenous/endogenous TNF (EET) therapy with cyclophosphamide on C6 glioma in ratS Ohshiro, H Inagawa, G Soma, et al.
The International Journal of Biochemistry|January 1, 1994
Constitutive expression of TNF-alpha and -beta genes in mouse embryo: roles of cytokines as regulator and effector on developmentC Kohchi, K Noguchi, Y Tanabe, et al.
Diseases of the Colon and Rectum|October 1, 1995
Inducibility of endogenous tumor necrosis factor by tumor cells from colorectal tumor patients at Dukes stage C as a novel prognostic factor following curative operationY Fukushima, E Tanizaki, K Takagi, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|January 1, 1995
Hemodynamic evaluation of recombinant human tumor necrosis factor (TNF)-alpha, TNF-SAM2 and liposomal TNF-SAM2 in an anesthetized dog modelR F Lodato, B Feig, K Akimaru, et al.
Cytokine|March 26, 1998
Involvement of 26-kDa membrane-bound tumour necrosis factor precursor in bidirectional feedback regulation on 17-kDa tumour necrosis factor production after stimulation by lipopolysaccharideY Tanabe, C Kohchi, N Kitahara-Tanabe, et al.
Chemical & Pharmaceutical Bulletin|February 1, 1991
Post-translational processing of tumor necrosis factor productionN Kitahara-Tanabe, Y Tanabe, A Morikawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 1, 1987
[Partial response of lung metastases from a renal cancer treated with endogenous tumor necrosis factor]M Kato, D Ishiwata, R Kakehi, et al.
Anticancer Research|December 17, 1998
Mechanisms by which chemotherapeutic agents augment the antitumor effects of tumor necrosis factor: involvement of the pattern shift of cytokines from Th2 to Th1 in tumor lesionsH Inagawa, T Nishizawa, T Honda, et al.
Anticancer Research|September 1, 1996
Induction of tumor necrosis factor by a camptothecin derivative, irinotecan, in mice and human mononuclear cellsS Goto, T Okutomi, Y Suma, et al.
In Vivo (Athens, Greece)|July 1, 1996
Selective lysis of early embryonic cells by the alternative pathway of complement--a possible mechanism for programmed cell death in embryogenesisR Kircheis, L Kircheis, H Oshima, et al.
Pageof 9

Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
Cancer Biotherapy|January 1, 1994
Antitumor effect of exogenous/endogenous TNF (EET) therapy with cyclophosphamide on C6 glioma in ratS Ohshiro, H Inagawa, G Soma, et al.
The International Journal of Biochemistry|January 1, 1994
Constitutive expression of TNF-alpha and -beta genes in mouse embryo: roles of cytokines as regulator and effector on developmentC Kohchi, K Noguchi, Y Tanabe, et al.
Diseases of the Colon and Rectum|October 1, 1995
Inducibility of endogenous tumor necrosis factor by tumor cells from colorectal tumor patients at Dukes stage C as a novel prognostic factor following curative operationY Fukushima, E Tanizaki, K Takagi, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|January 1, 1995
Hemodynamic evaluation of recombinant human tumor necrosis factor (TNF)-alpha, TNF-SAM2 and liposomal TNF-SAM2 in an anesthetized dog modelR F Lodato, B Feig, K Akimaru, et al.
Cytokine|March 26, 1998
Involvement of 26-kDa membrane-bound tumour necrosis factor precursor in bidirectional feedback regulation on 17-kDa tumour necrosis factor production after stimulation by lipopolysaccharideY Tanabe, C Kohchi, N Kitahara-Tanabe, et al.
Chemical & Pharmaceutical Bulletin|February 1, 1991
Post-translational processing of tumor necrosis factor productionN Kitahara-Tanabe, Y Tanabe, A Morikawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 1, 1987
[Partial response of lung metastases from a renal cancer treated with endogenous tumor necrosis factor]M Kato, D Ishiwata, R Kakehi, et al.
Anticancer Research|December 17, 1998
Mechanisms by which chemotherapeutic agents augment the antitumor effects of tumor necrosis factor: involvement of the pattern shift of cytokines from Th2 to Th1 in tumor lesionsH Inagawa, T Nishizawa, T Honda, et al.
Anticancer Research|September 1, 1996
Induction of tumor necrosis factor by a camptothecin derivative, irinotecan, in mice and human mononuclear cellsS Goto, T Okutomi, Y Suma, et al.
In Vivo (Athens, Greece)|July 1, 1996
Selective lysis of early embryonic cells by the alternative pathway of complement--a possible mechanism for programmed cell death in embryogenesisR Kircheis, L Kircheis, H Oshima, et al.
Pageof 9